Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter F Wright

Showing results (61-70 of 155) with videos related to

Pageof 16
Sort By:
AIDS Research and Human Retroviruses|December 19, 2002
Detection of mucosal antibodies in HIV type 1-infected individualsPeter F Wright, Pamela A Kozlowski, G Kyle Rybczyk, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 10, 2009
Risk factors for HIV infection among Haitian adolescents and young adults seeking counseling and testing in Port-au-PrinceTsogzolmaa Dorjgochoo, Francine Noel, Marie Marcelle Deschamps, et al.
Vaccine|August 24, 2013
The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteersAnna P Durbin, Peter F Wright, Amber Cox, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2025
Vaccine and Treatment Evaluation Units: A Historical PerspectiveRobert B Belshe, David I Bernstein, Kathryn M Edwards, et al.
The Journal of Infectious Diseases|April 19, 2008
Primary vaccine failure after 1 dose of varicella vaccine in healthy childrenDavid E Michalik, Sharon P Steinberg, Philip S Larussa, et al.
The New England Journal of Medicine|January 30, 2004
Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and childrenJohn V Williams, Paul A Harris, Sharon J Tollefson, et al.
Vaccine|May 9, 2022
Corrigendum to "Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized active-controlled trial" [Vaccine 40(19) (2022) 2705-2713]Jessica W Crothers, Elizabeth Ross Colgate, Kelly J Cowan, et al.
The American Journal of Tropical Medicine and Hygiene|March 2, 2016
Effectiveness of Oral Cholera Vaccine in Haiti: 37-Month Follow-UpKarine Sévère, Vanessa Rouzier, Stravinsky Benedict Anglade, et al.
The American Journal of Tropical Medicine and Hygiene|August 5, 2016
In ResponseKarine Sévère, Vanessa Rouzier, Stravinsky Benedict Anglade, et al.
Mucosal Immunology|July 9, 2021
Mucosal immunity to poliovirusRuth I Connor, Elizabeth B Brickley, Wendy F Wieland-Alter, et al.
Pageof 16

Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
AIDS Research and Human Retroviruses|December 19, 2002
Detection of mucosal antibodies in HIV type 1-infected individualsPeter F Wright, Pamela A Kozlowski, G Kyle Rybczyk, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 10, 2009
Risk factors for HIV infection among Haitian adolescents and young adults seeking counseling and testing in Port-au-PrinceTsogzolmaa Dorjgochoo, Francine Noel, Marie Marcelle Deschamps, et al.
Vaccine|August 24, 2013
The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteersAnna P Durbin, Peter F Wright, Amber Cox, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2025
Vaccine and Treatment Evaluation Units: A Historical PerspectiveRobert B Belshe, David I Bernstein, Kathryn M Edwards, et al.
The Journal of Infectious Diseases|April 19, 2008
Primary vaccine failure after 1 dose of varicella vaccine in healthy childrenDavid E Michalik, Sharon P Steinberg, Philip S Larussa, et al.
The New England Journal of Medicine|January 30, 2004
Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and childrenJohn V Williams, Paul A Harris, Sharon J Tollefson, et al.
Vaccine|May 9, 2022
Corrigendum to "Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized active-controlled trial" [Vaccine 40(19) (2022) 2705-2713]Jessica W Crothers, Elizabeth Ross Colgate, Kelly J Cowan, et al.
The American Journal of Tropical Medicine and Hygiene|March 2, 2016
Effectiveness of Oral Cholera Vaccine in Haiti: 37-Month Follow-UpKarine Sévère, Vanessa Rouzier, Stravinsky Benedict Anglade, et al.
The American Journal of Tropical Medicine and Hygiene|August 5, 2016
In ResponseKarine Sévère, Vanessa Rouzier, Stravinsky Benedict Anglade, et al.
Mucosal Immunology|July 9, 2021
Mucosal immunity to poliovirusRuth I Connor, Elizabeth B Brickley, Wendy F Wieland-Alter, et al.
Pageof 16